Merck Millipore Launches Provantage™ Solutions at BIO 2012

• Increases control and flexibility for small and large molecule development and manufacturing processes while decreasing time to market

June 20, 2012, Darmstadt, Germany — Merck Millipore, the Life Science division of Merck KGaA, today announced the launch of their Provantage™ Solutions, world-class process development, manufacturing consulting and implementation services, provided by Merck Millipore scientists, engineers, and applications specialists. The new offering, launched at BIO 2012 in Boston, Massachusetts, can be delivered either onsite at a drug manufacturer’s facility, at Merck Millipore’s advanced bioproduction facility in Martillac, France or at one of their six access labs around the world.

Provantage™ Solutions seamlessly complement biopharm and pharmaceutical companies’ internal capabilities and expertise and are customized with the optimal mix of products, services, consulting, and project management. Provantage™ Solutions provide greater control and increased flexibility for both small and large molecule development and manufacturing processes.

“Until now, the options for process development and manufacturing were limited to internal resources or conventional outsourcing,” describes Christophe Couturier, Vice President of Services and Solutions, Merck Millipore.  “While each option has pros and cons, Provantage™ Solutions integrates the best of each and helps accelerate the journey of a molecule to commercial phase.”

Initial offerings include:

Provantage™ Biodevelopment and Clinical Supply Solutions

• An innovative solution for biologics manufacturing that incorporates the latest technologies in upstream, downstream and single-use systems
• Includes process development and validation services
• GMP production for pre-clinical to phase II
• Technology transfer and scale-up services for phase III and commercial production

Provantage™ Bioprocess Consulting Solutions

• A wide range of projects with defined milestones, deliverables and business outcomes – from upstream all the way to commercial tech transfer
• Applies expertise, products, services and technology to help solve a client’s business problem or challenge

Provantage™ Solutions incorporate Merck Millipore’s unique blend of expertise across the development and manufacturing spectrum with an in-depth understanding of individual unit operations and applications. This allows delivery of optimized solutions that take into account the entire upstream and downstream operation.

The launch of Provantage™ Solutions occurred at an invite only event at BIO 2012 in the Boston Convention Center, Boston, Massachusetts, entitled: “Le Tour de Force: The Journey to Clinic.”

For additional information about Provantage™ Solutions please visit: www.merckmillipore.com/provantage.

About Merck Millipore
Merck Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers’ success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of life science.

Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 67 countries and 2011 revenues of EUR 2.4 billion. Merck Millipore operates as EMD Millipore in the U.S. and Canada.

Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany